Medical Discount Blog

THURSDAY, Feb. 28 (HealthDay news) — Nexium, a popular drug to use gastroesophageal reflux disease (GERD) in adults, has been approved notwithstanding the same short-term use in children ages 1 to 11, the U.S. Food and Drug Administration said Thursday.

Two forms of Nexium (esomeprazole magnesium) were approved for younger children — a delayed-release covering and a liquid form. Doses approved for this age group are half of those approved for older children, the mediation said. The mix with drugs was antecedently approved instead of children ages 12 to 17.

nexium is among a class of drugs called proton pump inhibitors, which limit production of stomach acid and help heal eating away of the lining of the gullet.

Common espouse a cause effects among younger children who used Nexium were headache, diarrhea, abdominal pain relief/muscle relaxant, nausea, gas, constipation, dry mouth, and fatigue. The drug's safety and effectiveness haven't been evaluated in children younger than 1 year old, the FDA said.